Pre-hospital Risk Factors for Invasive Fungal Infection (SEIFEM 2010)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Catholic University of the Sacred Heart.
Recruitment status was  Recruiting
Information provided by:
Catholic University of the Sacred Heart Identifier:
First received: March 15, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted

SEIFEM 2010 study is a prospective, multicenter registry designed to identify and analyze risk factors for developing an invasive fungal infection in patients with newly diagnosed Acute Myeloid Leukemia, with particular interest on pre-hospital risk factors (i.e. those related to normal activities of daily life, such as occupation, location and type of residence, consume of tobacco, alcohol and others).

Acute Myeloid Leukemia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: SEIFEM 2010: Epidemiological Survey on Possible Pre-Hospital Risk Factors for Developing Invasive Fungal Infections in Patients Affected by Acute Myeloid Leukemia

Resource links provided by NLM:

Further study details as provided by Catholic University of the Sacred Heart:

Primary Outcome Measures:
  • Incidence of Invasive fungal infections [ Time Frame: 30th day after the end of first line chemotherapy ] [ Designated as safety issue: No ]
    To identify possible fungal infections sources for the period preceding the diagnosis of leukemia, in particular those related to normal activities of daily life (e.g. occupation, location and type of residence, consume of tobacco, alcohol or illicit drugs and others).

Estimated Enrollment: 1000
Study Start Date: January 2010
Newly disgnosed AML
Adult and pediatric patients with newly diagnosed acute myeloid leukemia, both eligible and not eligible for intensive chemotherapy. Since this is a non-interventional study, therapeutic strategies remains related to local guidelines. Will be treated as cases all patients with acute leukemia in first induction developing an Invasive Fungal Infection according to international EORTC criteria for possible/probable/proven infections. Patients who do not develop the infection will be used as a control group.

  Show Detailed Description


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult and pediatric patients with newly diagnosed acute myeloid leukemia, both eligible and not eligible for intensive chemotherapy.


Inclusion Criteria:

  • all newly diagnosed AML who accept to take part to the registry and sign an informed consent

Exclusion Criteria:

  • relapsing/refractory AML
  • patients who do not sign informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01315925

University of Ancona Recruiting
Ancona, AN, Italy
Contact: Massimo Offidani, MD   
Principal Investigator: Massimo Offidani, MD         
University of Bary Recruiting
Bari, BA, Italy
Contact: Mario Delia, MD   
Principal Investigator: Giorgina Specchia         
Sub-Investigator: Mario Delia         
University of Bologna Recruiting
Bologna, BO, Italy
Contact: Nicola Vianelli   
Principal Investigator: Nicola Vianelli         
University of Firenze Recruiting
Firenze, FI, Italy
Contact: Rosa Fanci, MD   
Principal Investigator: Rosa Fanci         
Tricase Hospital Recruiting
Tricase, LE, Italy
Contact: Vincenzo Pavone   
Niguarda Hospital Recruiting
Milano, MI, Italy
Contact: Annamaria Nosari, MD   
Principal Investigator: Annamaria Nosari, MD         
Catholic University Recruiting
Rome, RM, Italy, 00168
Contact: Livio Pagano, MD    +390630154180   
Principal Investigator: Livio Pagano, MD         
Sub-Investigator: Morena Caira, MD         
Sub-Investigator: Mario Mancinelli, MD         
IFO Active, not recruiting
Rome, RM, Italy
S.Camillo Hospital Recruiting
Rome, RM, Italy
Contact: Maria Grazia Garzia   
S.Giovanni Hospital Recruiting
Rome, RM, Italy
Contact: Anna Chierichini   
University of Tor Vergata Recruiting
Rome, RM, Italy
Contact: Adriano Venditti   
Le Molinette Hospital Recruiting
Torino, TO, Italy
Contact: Alessandro Busca   
Hospital of Brescia Recruiting
Brescia, Italy
Contact: Chiara Cattaneo, MD   
Sub-Investigator: Chiara Cattaneo         
Principal Investigator: Giuseppe Rossi         
University of Cagliari Recruiting
Cagliari, Italy
Contact: Adriana Vacca   
Catholic University Recruiting
Campobasso, Italy
Contact: Cristina Gasbarrino   
Principal Investigator: Sergio Storti         
Cuneo Hospital Active, not recruiting
Cuneo, Italy
Istotuto Meyer Recruiting
Firenze, Italy
Contact: Desiree Caselli   
Gaslini Hospital Recruiting
Genova, Italy
Contact: Elio Castagnola   
La Spezia Hospital Recruiting
La Spezia, Italy
Contact: Annunziata Manna   
Lecce Hospital Recruiting
Lecce, Italy
Contact: De Paolis   
Lecce Pediatric Hospital Active, not recruiting
Lecce, Italy
University of Modena e Reggio Recruiting
Modena, Italy
Contact: Mario Luppi   
Principal Investigator: Mario Luppi         
Monza Hospital Recruiting
Monza, Italy
Contact: Luisa Verga   
San Gerardo Hospital Active, not recruiting
Monza, Italy
"Federico II" University Recruiting
Napoli, Italy
Contact: Marco Picardi, MD   
Cardarelli Hospital Active, not recruiting
Napoli, Italy
Pausilion Hospital Active, not recruiting
Napoli, Italy
University of Palermo Recruiting
Palermo, Italy
Contact: Maria Enza Mitra   
Principal Investigator: Maria Enza Mitra         
University of Parma Recruiting
Parma, Italy
Contact: Cecilia Caramatti   
S.Matteo Hospital, Department of Hematology Recruiting
Pavia, Italy
Contact: Carlo Castagnola   
Principal Investigator: Carlo Castagnola         
S.Matteo Hospital, Department of Medicine Recruiting
Pavia, Italy
Contact: Rosangela Invernizzi   
University of Perugia Recruiting
Perugia, Italy
Contact: Franco Aversa   
Principal Investigator: Franco Aversa         
University of Perugia, Pediatric Hematology Recruiting
Perugia, Italy
Contact: Franco Aversa   
Pescara Hospital Recruiting
Pescara, Italy
Contact: Prassede Salutari   
Reggio Calabria Hospital Recruiting
Reggio Calabria, Italy
Contact: Bruno Martino   
Reggio Emilia Hospital Recruiting
Reggio Emilia, Italy
Contact: Alessandro Bonini   
"Padre Pio" Hospital Recruiting
San Giovanni Rotondo, Italy
Contact: Lorella Melillo   
S.Anna Hospital Recruiting
Torino, Italy
Contact: Mareva Giacchino   
Regina Margherita Hospital Active, not recruiting
Torino, Italy
University of Udine Recruiting
Udine, Italy
Contact: Anna Candoni   
University of Verona Recruiting
Verona, Italy
Contact: Gianpaolo Nadali   
Verona Hospital Recruiting
Verona, Italy
Contact: Simone Cesaro   
Sponsors and Collaborators
Catholic University of the Sacred Heart
  More Information

Additional publications automatically indexed to this study by Identifier (NCT Number):
Caira M, Candoni A, Verga L, Busca A, Delia M, Nosari A, Caramatti C, Castagnola C, Cattaneo C, Fanci R, Chierichini A, Melillo L, Mitra ME, Picardi M, Potenza L, Salutari P, Vianelli N, Facchini L, Cesarini M, De Paolis MR, Di Blasi R, Farina F, Venditti A, Ferrari A, Garzia M, Gasbarrino C, Invernizzi R, Lessi F, Manna A, Martino B, Nadali G, Offidani M, Paris L, Pavone V, Rossi G, Spadea A, Specchia G, Trecarichi EM, Vacca A, Cesaro S, Perriello V, Aversa F, Tumbarello M, Pagano L; SEIFEM Group (Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne). Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study). Haematologica. 2015 Feb;100(2):284-92. doi: 10.3324/haematol.2014.113399.

Responsible Party: Livio Pagano, MD, Catholic University of the Sacred Heart Identifier: NCT01315925     History of Changes
Other Study ID Numbers: 751/2009
Study First Received: March 15, 2011
Last Updated: March 15, 2011
Health Authority: Italy: Ethics Committee

Keywords provided by Catholic University of the Sacred Heart:
Acute myeloid leukemia
invasive fungal infection

Additional relevant MeSH terms:
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Neoplasms by Histologic Type
Skin Diseases
Skin Diseases, Infectious processed this record on October 06, 2015